{"id":"NCT01454284","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Participants With Type I Diabetes Mellitus","officialTitle":"The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 1 Diabetes Mellitus Treated With Preprandial Insulin Lispro: a Double-Blind, Randomized, 52-week Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2014-02","completion":"2014-02","firstPosted":"2011-10-18","resultsPosted":"2018-04-17","lastUpdate":"2018-04-17"},"enrollment":1114,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"Glargine","otherNames":[]},{"type":"DRUG","name":"LY2605541","otherNames":[]},{"type":"DRUG","name":"Insulin Lispro","otherNames":["LY275585","Humalog"]}],"arms":[{"label":"LY2605541 + Insulin Lispro","type":"EXPERIMENTAL"},{"label":"Glargine + Insulin Lispro","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is:\n\n* To compare blood sugar control on LY2605541 with insulin glargine after 52 weeks of treatment.\n* To compare the rate of nocturnal low blood sugar episodes on LY2605541 with insulin glargine during 52 weeks of treatment.\n* To compare the number of participants on LY2605541 reaching blood sugar targets without low blood sugar episodes at night to those taking insulin glargine after 52 weeks of treatment.\n* To compare the rate of low blood sugar episodes on LY2605541 with insulin glargine during 52 weeks of treatment","primaryOutcome":{"measure":"Hemoglobin A1c (HbA1c)","timeFrame":"52 weeks","effectByArm":[{"arm":"LY2605541 + Insulin Lispro","deltaMin":7.38,"sd":0.03},{"arm":"Insulin Glargine + Insulin Lispro","deltaMin":7.61,"sd":0.04}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":119,"countries":["United States","Australia","Belgium","Brazil","Canada","Croatia","Denmark","France","Greece","Ireland","Israel","Lithuania","Netherlands","New Zealand","Poland","Slovakia","South Africa","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["36542287","29167192","28587667","28417532"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":117,"n":663},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Influenza","Lipohypertrophy","Cough"]}}